Market revenue in 2023 | USD 369.2 million |
Market revenue in 2030 | USD 650.0 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Anti-vegf agents |
Fastest growing segment | Anti-VEGF agents |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Allergy, Anti-VEGF agents, Anti-inflammatory, Anti-glaucoma |
Key market players worldwide | Pfizer Inc, Alcon Inc, Novartis AG ADR, Bausch Health Companies Inc, Merck & Co Inc, Regeneron Pharmaceuticals Inc, AbbVie Inc, Bayer AG, Genentech, Nicox SA Share from reverse split, Coherus BioSciences Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic drugs market will help companies and investors design strategic landscapes.
Anti-vegf agents was the largest segment with a revenue share of 32.8% in 2023. Horizon Databook has segmented the Sweden ophthalmic drugs market based on anti-allergy, anti-vegf agents, anti-inflammatory, anti-glaucoma covering the revenue growth of each sub-segment from 2018 to 2030.
In Sweden, there is a high prevalence of retinal disease, which creates a significant demand for therapeutics in the country. There are several approved drugs for the treatment of dry eye disease in the country. However, key players in the market are continuously focusing on developing novel therapeutics to address the condition in the country.
For instance, in September 2020, Redwood Pharma launched a program for the development of treatment for dry eye based on IntelliGel. Moreover, in December 2022, iSTAR Medical announced the commercial launch of MINIject, which would be used in decreasing intraocular pressure, in Sweden and Norway.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden ophthalmic drugs market , including forecasts for subscribers. This country databook contains high-level insights into Sweden ophthalmic drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account